Low-dose Synachten test with measurement of salivary cortisol in adult patients with β-thalassemia major

Research output: Contribution to journalArticlepeer-review


PURPOSE: Beta-thalassemia major is a severe, congenital hematological disorder and, if untreated, leads to early mortality. Progress in therapeutical strategies improved clinical outcomes and life expectancy; however, increased survival led to the development of new disorders, including endocrinopathies. Little is known on the possible impairment of adrenocortical function, a potentially life-threatening condition, in long-term thalassaemic survivors. We therefore decided to assess adrenal reserve and the value of salivary cortisol during ACTH stimulation in the diagnosis of adrenocortical insufficiency in adult patients with β-thalassemia major.METHODS: Cross-sectional study including 72 adults with β-thalassemia major. Patients were tested with 1 µg ACTH for serum and salivary cortisol.RESULTS: Subnormal serum cortisol responses to ACTH stimulation (i.e.,
Original languageItalian
Pages (from-to)348-354
Number of pages7
Issue number2
Publication statusPublished - May 2018

Cite this